ALTANA AG Takes Minority Equity Stake in GPC Biotech AG
"We are delighted to have ALTANA as a new strategic investor. This reflects ALTANA's strong support of GPC Biotech as well as its satisfaction with our ongoing alliances. ALTANA's substantial investment further solidifies GPC Biotech's already strong cash position", commented Bernd R. Seizinger, M.D., Ph.D., President and CEO of GPC Biotech.
"GPC Biotech belongs to the most interesting and sophisticated transatlantic biotech companies with locations in Germany and the US. GPC Biotech has proved itself in a reliable and competent partnership which builds the foundation for our entrance as strategic investor", said Dr. Hans-Joachim Lohrisch, member of the managing board of ALTANA AG.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.